(Updated - September 3, 2014 12:56 PM EDT)Wedbush upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Underperform to Neutral and raised its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE